Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

NCT06834035 is registered in ClinicalTrials.gov with M. Peter Marinkovich as lead sponsor.

NCT NCT06834035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06834035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Lead sponsor
M. Peter Marinkovich
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 4, 2025
Completion date
March 31, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophic epidermolysis bullosa, epidermolysis bullosa, epidermolysis bullosa acquisita, recessive dystrophic epidermolysis bullosa